Triad National Security, LLC

Los Alamos National Security, LLC

Michael E Fassbender

Tara E Mastren

Valery Radchenko

Eva Rachel Birnbaum

Francois Nortier

Kevin John

Jonathan Ward Engle

Stosh Anthony Kozimor

Beau D Ballard

Benjamin W Stein

Justin Wilson

Disclosed herein are embodiments of an extractant that can be used for chromatographic isolation of radioisotopes and/or metal species. The extractant can be combined with a support medium to provide an extractant composition that selectively and efficiently binds particular radioisotopes and/or metal species. Also disclosed herein are embodiments of a method for using the disclosed extractant embodiments, as well as embodiments of a method for making the extractant and extractant composition.

Extractants and extractant compositions for radioisotope and metal recovery

Disclosed herein are embodiments of a method for producing thorium-226. The method comprises separating thorium-226 from uranium-230 to produce a solution of thorium-226 in a solvent, such as a chelating buffer, suitable for direct labeling by a chelate. The thorium-226 may be separated from the uranium-230 using extraction chromatography. The extraction may be repeated multiple times as additional thorium-226 is produced by uranium-230 decay.

Method for producing thorium-226

Selective chelation of bismuth radionuclide ions from a mixture including actinium radionuclide ions involves exposing a ligand to an aqueous solution that includes bismuth radionuclide ions and actinium radionuclide ions under conditions whereby the bismuth radionuclide ions selectively chelate to the ligand for form cationic complexes of the bismuth radionuclide ions. and separating the cationic complexes of the bismuth radionuclide ions from the actinium radionuclide ions. The ligands have a structure based on a 12-membered cyclen ring and may include pendant functional groups that can be derivatized with biological targeting vectors for targeted alpha therapy.

Nitrogen-rich macrocyclic ligands, chelation complexes thereof, and process for selective chelation of radioactive bismuth ions with the ligands

Protactinium, actinium, radium, radiolanthanides and other radionuclide fission products were separated and recovered from a proton-irradiated thorium target. The target was dissolved in concentrated HCl, which formed anionic complexes of protactinium but not with thorium, actinium, radium, or radiolanthanides. Protactinium was separated from soluble thorium by loading a concentrated HCl solution of the target onto a column of strongly basic anion exchanger resin and eluting with concentrated HCl. Actinium, radium and radiolanthanides elute with thorium. The protactinium that is retained on the column, along with other radionuclides, is eluted may subsequently treated to remove radionuclide impurities to afford a fraction of substantially pure protactinium. The eluate with the soluble thorium, actinium, radium and radiolanthanides may be subjected to treatment with citric acid to form anionic thorium, loaded onto a cationic exchanger resin, and eluted. Actinium, radium and radiolanthanides that are retained can be subjected to extraction chromatography to separate the actinium from the radium and from the radio lanthanides.

Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target

The preparation of aSe/As radioisotope generator involves forming an acidic aqueous solution of an irradiated alkali bromide target such as a NaBr target, oxidizing soluble bromide in the solution to elemental bromine, removing the elemental bromine, evaporating the resulting solution to a residue, removing hydrogen chloride from the residue, forming an acidic aqueous solution of the residue, adding a chelator that selectively forms a chelation complex with selenium, and extracting the chelation complex from the acidic aqueous solution into an organic phase. As theSe generatesAs in the organic phase, theAs may be extracted repeatedly from the organic phase with an aqueous acid solution.

Growing community of inventors

Los Alamos, NM, United States of America

Michael E Fassbender